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Early
Defervescence and
SARS Recovery
To the Editor: Severe acute respi-
ratory syndrome (SARS) is an emerg-
ing disease first recognized
November 2002 (1). Previous studies
show patients with probable SARS on
ribavirin and steroid therapy may
experience a biphasic course, with
clinical symptoms and changes shown
on chest x-rays increasing in the sec-
ond week of disease (2). We report a
patient with probable SARS who had
temporary defervescence for 7 days
before rapidly progressing to respira-
tory failure. 
The patient was a 54-year-old
female nursing aide for a patient with
fever and pneumonia who was diag-
nosed with probable SARS on the
basis of the criteria proposed by
World Health Organization (WHO)
(3). Our patient did not have underly-
ing disease, but fever of 38.6°C devel-
oped on May 10, 2003, a total of 3
days after her last contact with the
patient she was caring for. Mild myal-
gia was noted. She was admitted that
day with suspected SARS. Initial
chest x-ray results were normal.
Hemogram showed a normal leuko-
cyte count with mild lymphopenia
(absolute lymphocyte count 0.84 x
109/L) and a normal platelet count
(253 x 109/L). Initial serum aspartate
aminotransferase (AST) and alanine
aminotransferase (ALT) levels were
38 U/L and 20 U/L, respectively (nor-
mal <35 U/L). Serum creatinine
kinase (CK) level was 84 U/L(normal
<190 U/L). Serum C-reactive protein
(CRP) level was elevated (3.49
mg/dL; normal <0.8 mg/dL). Serum
sodium level was normal.
After admission, she received oral
ribavirin, 1,000 mg/day. No other
antimicrobial agent was administered.
Her fever persisted for 2 days, and she
became afebrile spontaneously on
May 13, 2003. The result of reverse
transcription–polymerase chain reac-
tion (RT-PCR) for SARS-associated
coronavirus (SARS-CoV) on a throat
swab specimen performed on May 10
was negative. All other testing, includ-
ing blood culture; virus isolation; and
serologic tests for SARS-CoV,
chlamydiae, mycoplasmas, rickettsiae,
influenza virus, parainfluenza virus,
adenovirus, respiratory syncytial virus
(RSV), and coxsackie virus were also
negative. She did not take any nons-
teroid antiinflammatory drugs
(NSAIDs) or steroids during this peri-
od. Her chest x-ray results on May 13
remained normal. Other laboratory
testing on May 13 showed resolution
of lymphopenia, a lower serum CRP
level (2.48 mg/dL), but an elevated
lactate dehydrogenase (LDH) level
(627 U/L; normal <460 U/L).
During the next 4 days, she
remained afebrile. Results of a repeat-
ed chest x-ray on May 16 were still
normal. The serum CRP level
decreased to 2.29 mg/dL. However,
borderline leukopenia (4.45 x 109/L),
borderline thrombocytopenia (167 x
109/L), an elevated serum CK level
(238 U/L), hyponatremia (128.2
mmol/L), and a progressively elevat-
ed serum LDH level (1,138 U/L) were
noted. Because she had been afebrile
for 5 days, she was discharged on
May 17. After discharge, she contin-
ued to take ribavirin and be quaran-
tined at home. Unfortunately, fever
and rapidly progressive dyspnea
developed on May 20. On the same
day, chest x-ray showed diffusely
increased infiltration over all lung
zones. Hemogram showed leukocyto-
sis (leukocyte count 14.03 x 109/L).
Serum CRPlevel was elevated to 12.7
mg/dL. Serum sodium level was
129.5 mmol/L. Serum AST level was
135 U/L, serum CK level was 71 U/L,
and serum LDH level was 1,719 U/L.
All blood cultures and sputum culture
for bacteria yielded nothing.
She was intubated on May 21 for
respiratory failure. Under the assump-
tion of probable SARS, she was given
high-dose methylprednisolone (120
mg/day), and her clinical condition
stabilized soon after. The results of
RT-PCR for SARS-CoV on a throat
swab specimen performed on May 21
were positive. The results of immuno-
fluorescent assays testing for
immunoglobulin (Ig) M and IgG
against SARS-CoV (performed in the
research laboratory at National
Taiwan University Hospital on May
21 and 27) were all positive (both IgM
titers >1:10; both IgG titers >1:1,000).
Sputum culture and Gram stain were
both negative. Urine tests were also
negative for pneumococcal and
Legionella antigens. Other serologic
tests, including those for chlamydiae,
mycoplasmas, rickettsiae, influenza
virus, parainfluenza virus, adenovirus,
RSV, and coxsackie virus were still
negative. The ventilator was removed
on June 9. 
A previous report pointed out the
great variety in the clinical course of
SARS (4). We emphasize that even a
patient with suspected SARS who
became afebrile in the first week and
remained so for 7 days without steroid
or NSAID treatment still risks deteri-
oration in the second week, as long as
some laboratory values remain abnor-
mal. Therefore, defervescence, even
up to 7 days, may not be the single
indicator for discharging SARS
patients. Obtaining normal results for
previously abnormal laboratory
parameters, including hemogram,
CRP, CK, AST, ALT, and LDH levels
should be considered when deciding
whether a patient can be safely dis-
charged (5). 
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Babesiosis in
Fairfield County,
Connecticut 
To the Editor: Human babesiosis,
caused by Babesia microti, was ini-
tially described in the eastern United
States in 1970 in a woman vacation-
ing on Nantucket Island,
Massachusetts (1). With few excep-
tions, almost all subsequent cases
were recorded from islands in the
northeastern United States and Cape
Cod, Massachusetts (2), until this ill-
ness was diagnosed in 13 patients liv-
ing in New London County in south-
eastern Connecticut (3,4). B. microti
was isolated from white-footed mice,
Peromyscus leucopus, captured from
1988 to 1990 in the yards of patients.
Babesiosis also was diagnosed in per-
sons living in Wisconsin (5) and in
New Jersey (6) who acquired the
organism locally.  The number of
cases of babesiosis reported by health
departments on their Web sites and by
personal communication in Massa-
chusetts, Rhode Island, and New York
State, was 330 from 1988 to 2002,
121 from 1994 to 2002, and 542 from
1986 to 2001, respectively.  The num-
ber of cases reported by the New York
City Health Department from 1991 to
2000 was 75.
From 1991 to 2000, babesiosis was
diagnosed in 230 persons residing in
New London County and adjacent
Middlesex County, Connecticut (7).
Fifty-three additional cases were
reported in five other counties in
Connecticut, but epidemiologic data
did not indicate that these infections
likely were acquired within
Connecticut. We now note a new and
distinct geographic focus by reporting
the isolation of B. microti from
rodents captured in the yards of two
patients in whom babesiosis was diag-
nosed at Greenwich Hospital in 2002.
These patients lived in Greenwich,
Connecticut, which is located in
Fairfield County in the extreme south-
western part of the state. Neither
patient had traveled outside of the
immediate area of Greenwich,
Connecticut, before onset of illness.
We also trapped rodents in the yards
of two additional patients in whom
babesiosis was diagnosed. These two
patients had traveled to Rhode Island
shortly before becoming ill. Patients
became ill from June 23 to July 7,
2002, and none reported a tick bite.
Attempts to trap small mammals
on the properties of the four patients
were made on July 22, 23, and 29,
2002. Rodents were captured in
Sherman box traps baited with peanut
butter and apple. Approximately 0.3
mLof blood was drawn from the heart
of each animal into a syringe coated
with heparin or uncoated. Blood was
kept on ice in the field and then
returned to the laboratory. A 3- to 5-
week-old male Syrian hamster was
injected intraperitoneally with 0.1 mL
of each blood sample.
Blood smears were obtained from
a drop of blood taken from the tail of
each hamster on weeks 3 to 6 after
injection. Blood cells were stained
with Giemsa and examined for B.
microti at a magnification of 1,008x.
Hamsters were considered uninfected
when no parasites were found in 75
fields of stained erythrocytes.  
B. microti was isolated from
rodents captured at the residences of
two of the patients who did not travel
outside of the Greenwich area 6
weeks before onset of illness. Blood
from two of three white-footed mice
and from the two eastern chipmunks,
Tamias striatus, captured in the yards
of the patients, produced infections in
injected hamsters. Infections did not
develop in hamsters injected with
blood from 10 white-footed mice cap-
tured at the residences of two patients
who visited Wakefield and Charles-
town, Rhode Island, shortly before
becoming ill.
B. microti is prevalent in rodent
populations in Greenwich, Connec-
ticut, and causes human disease.
Establishing evidence of B. microti in
rodents and documenting this proto-
zoan parasite as the cause of human
disease in Greenwich are important.
Relatively high populations of the
vector tick, Ixodes scapularis, are
present in Greenwich and nearby
towns. In 2002, the health depart-
ments of Greenwich, Stamford, New
Canaan, and Darien submitted 1,671
I. scapularis ticks removed from per-
sons to the Connecticut Agricultural
Experiment Station for identification
and testing for Borrelia burgdorferi.
Two hundred and thirty cases of Lyme
disease were reported from these four
towns in 2002 (Connecticut
Department of Public Health, unpub.
data). With such extensive human
exposure to ticks and a relatively large
number of Lyme disease cases in
these four towns and elsewhere in
Fairfield County, the number of cases
of babesiosis is likely to increase
appreciably in the future.
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